OPCH on Nasdaq
Option Care Health, Inc.
American home health care services company based in Bannockburn.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with AdaptHealth Corp., Chemed Corporation or BrightSpring Health Services, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
19.3%Gross margin3
6.0%Operating margin3
3.7%Net margin3
13.0%Revenue growth, 20253
15.7%Return on equity3
0.87×Debt to equity3
$217.1MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue81¢$4.6B
- Selling, general and admin12¢$682.5M
- Other costs2¢$122.5M
- Income tax1¢$75.3M
- Profit4¢$207.6M
Out of $5.6B in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending12¢$41.3M
- Share buybacks88¢$310.0M
Out of $258.4M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| NET REVENUE | $5.6B | $5.0B | $4.3B |
| COST OF REVENUE | $4.6B | $4.0B | $3.3B |
| GROSS PROFIT | $1.1B | $1.0B | $981.2M |
| Selling, general and administrative expenses | $682.5M | $630.3M | $607.4M |
| Depreciation and amortization expense | $67.5M | $60.9M | $59.2M |
| Total operating expenses | $750.0M | $691.2M | $666.6M |
| OPERATING INCOME | $337.9M | $321.8M | $314.6M |
| Interest expense, net | -$54.6M | -$49.0M | -$51.2M |
| Equity in earnings of joint ventures | $7.4M | $6.0M | $5.5M |
| Other, net | -$7.9M | $4.8M | $89.9M |
| Total other (expense) income | -$55.0M | -$38.2M | $44.1M |
| INCOME BEFORE INCOME TAXES | $282.9M | $283.6M | $358.7M |
| INCOME TAX EXPENSE | $75.3M | $71.8M | $91.7M |
| NET INCOME | $207.6M | $211.8M | $267.1M |
| Change in unrealized (loss) gain on cash flow hedges, net of income tax benefit (expense) of $2,272, $1,284, and $2,158, respectively | -$6.9M | -$3.9M | -$6.2M |
| OTHER COMPREHENSIVE (LOSS) INCOME | -$6.9M | -$3.9M | -$6.2M |
| NET COMPREHENSIVE INCOME | $200.6M | $207.9M | $260.9M |
| Earnings per share, basic (in dollars per share) | $1.28 | $1.23 | $1.49 |
| Earnings per share, diluted (in dollars per share) | $1.27 | $1.23 | $1.48 |
| Weighted average common shares outstanding, basic (in shares) | 162.1M shares | 171.6M shares | 179.0M shares |
| Weighted average common shares outstanding, diluted (in shares) | 163.4M shares | 172.8M shares | 180.4M shares |
| Change in unrealized (loss) gain on cash flow hedges, income tax benefit (expense) | $2.3M | $1.3M | $2.2M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $232.6M | $412.6M | ||
| Accounts receivable, net | $473.6M | $409.7M | ||
| Inventories | $471.1M | $388.1M | ||
| Prepaid expenses and other current assets | $87.6M | $112.2M | ||
| Total current assets | $1.3B | $1.3B | ||
| Property and equipment, net | $139.2M | $127.4M | ||
| Operating lease right-of-use asset | $91.2M | $86.5M | ||
| Intangible assets, net | $21.9M | $17.0M | ||
| Referral sources, net | $287.3M | $284.0M | ||
| Goodwill | $1.6B | $1.5B | $1.5B | $1.5B |
| Other noncurrent assets | $44.4M | $44.0M | ||
| Total noncurrent assets | $2.2B | $2.1B | ||
| TOTAL ASSETS | $3.5B | $3.4B | ||
| Accounts payable | $639.8M | $610.8M | ||
| Accrued compensation and employee benefits | $70.4M | $63.0M | ||
| Accrued expenses and other current liabilities | $88.3M | $77.8M | ||
| Current portion of operating lease liability | $24.0M | $22.0M | ||
| Current portion of long-term debt | $6.8M | $6.5M | ||
| Total current liabilities | $829.3M | $780.1M | ||
| Long-term debt, net of discount, deferred financing costs and current portion | $1.2B | $1.1B | ||
| Operating lease liability, net of current portion | $88.5M | $84.8M | ||
| Deferred income taxes | $56.0M | $47.6M | ||
| Other noncurrent liabilities | $1.4M | $366.0K | ||
| Total noncurrent liabilities | $1.3B | $1.2B | ||
| Total liabilities | $2.1B | $2.0B | ||
| Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock; $0.0001 par value: 250,000,000 shares authorized, 184,522,423 shares issued and 156,857,801 shares outstanding as of December 31, 2025; 183,846,725 shares issued and 166,261,112 shares outstanding as of December 31, 2024 | $18.0K | $18.0K | ||
| Treasury stock; 27,664,622 and 17,585,613 shares outstanding, at cost, as of December 31, 2025 and 2024, respectively | -$818.2M | -$507.6M | ||
| Paid-in capital | $1.3B | $1.2B | ||
| Retained earnings | $876.9M | $669.3M | ||
| Accumulated other comprehensive income (loss) | $4.1M | $11.0M | ||
| Total stockholders equity | $1.3B | $1.4B | $1.4B | $1.4B |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $3.5B | $3.4B | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 12.5M shares | 12.5M shares | ||
| Preferred stock, shares, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 250.0M shares | 250.0M shares | ||
| Common stock, shares, issued (in shares) | 184.5M shares | 183.8M shares | ||
| Common stock, shares, outstanding (in shares) | 156.9M shares | 166.3M shares | ||
| Treasury stock, shares (in shares) | 27.7M shares | 17.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $232.6M | $412.6M | ||
| Accounts receivable, net | $473.6M | $409.7M | ||
| Inventories | $471.1M | $388.1M | ||
| Prepaid expenses and other current assets | $87.6M | $112.2M | ||
| Total current assets | $1.3B | $1.3B | ||
| Property and equipment, net | $139.2M | $127.4M | ||
| Operating lease right-of-use asset | $91.2M | $86.5M | ||
| Intangible assets, net | $21.9M | $17.0M | ||
| Referral sources, net | $287.3M | $284.0M | ||
| Goodwill | $1.6B | $1.5B | $1.5B | $1.5B |
| Other noncurrent assets | $44.4M | $44.0M | ||
| Total noncurrent assets | $2.2B | $2.1B | ||
| TOTAL ASSETS | $3.5B | $3.4B | ||
| Accounts payable | $639.8M | $610.8M | ||
| Accrued compensation and employee benefits | $70.4M | $63.0M | ||
| Accrued expenses and other current liabilities | $88.3M | $77.8M | ||
| Current portion of operating lease liability | $24.0M | $22.0M | ||
| Current portion of long-term debt | $6.8M | $6.5M | ||
| Total current liabilities | $829.3M | $780.1M | ||
| Long-term debt, net of discount, deferred financing costs and current portion | $1.2B | $1.1B | ||
| Operating lease liability, net of current portion | $88.5M | $84.8M | ||
| Deferred income taxes | $56.0M | $47.6M | ||
| Other noncurrent liabilities | $1.4M | $366.0K | ||
| Total noncurrent liabilities | $1.3B | $1.2B | ||
| Total liabilities | $2.1B | $2.0B | ||
| Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of December 31, 2025 and 2024 | $0 | $0 | ||
| Common stock; $0.0001 par value: 250,000,000 shares authorized, 184,522,423 shares issued and 156,857,801 shares outstanding as of December 31, 2025; 183,846,725 shares issued and 166,261,112 shares outstanding as of December 31, 2024 | $18.0K | $18.0K | ||
| Treasury stock; 27,664,622 and 17,585,613 shares outstanding, at cost, as of December 31, 2025 and 2024, respectively | -$818.2M | -$507.6M | ||
| Paid-in capital | $1.3B | $1.2B | ||
| Retained earnings | $876.9M | $669.3M | ||
| Accumulated other comprehensive income (loss) | $4.1M | $11.0M | ||
| Total stockholders equity | $1.3B | $1.4B | $1.4B | $1.4B |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $3.5B | $3.4B | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 12.5M shares | 12.5M shares | ||
| Preferred stock, shares, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in shares) | 250.0M shares | 250.0M shares | ||
| Common stock, shares, issued (in shares) | 184.5M shares | 183.8M shares | ||
| Common stock, shares, outstanding (in shares) | 156.9M shares | 166.3M shares | ||
| Treasury stock, shares (in shares) | 27.7M shares | 17.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $207.6M | $211.8M | $267.1M |
| Depreciation and amortization expense | $70.7M | $63.5M | $62.2M |
| Non-cash operating lease costs | $25.0M | $22.6M | $18.5M |
| Deferred income taxes, net | $8.4M | $12.7M | $12.8M |
| Loss on extinguishment of debt | $4.7M | $377.0K | $0 |
| Amortization of deferred financing costs | $4.1M | $4.6M | $4.4M |
| Equity in earnings of joint ventures | -$7.4M | -$6.0M | -$5.5M |
| Stock-based incentive compensation expense | $40.0M | $36.1M | $30.5M |
| Distribution from equity method investments | $4.0M | $2.4M | $4.0M |
| Other adjustments | $1.0M | -$4.5M | -$1.2M |
| Accounts receivable, net | -$54.6M | -$32.1M | $224.0K |
| Inventories | -$81.5M | -$114.1M | -$51.0M |
| Prepaid expenses and other current assets | $17.8M | -$15.6M | -$6.3M |
| Accounts payable | $19.5M | $183.4M | $47.7M |
| Accrued compensation and employee benefits | $6.3M | -$29.5M | $15.5M |
| Accrued expenses and other current liabilities | $9.9M | $6.1M | -$1.7M |
| Operating lease liabilities | -$24.0M | -$21.9M | -$17.5M |
| Other noncurrent assets and liabilities | $6.9M | $3.4M | -$8.4M |
| Net cash provided by operating activities | $258.4M | $323.4M | $371.3M |
| Acquisition of property and equipment | -$41.3M | -$35.6M | -$41.9M |
| Proceeds from sale of assets | $0 | $0 | $3.7M |
| Business acquisitions, net of cash acquired | -$117.2M | $0 | -$12.5M |
| Other investing activities | -$2.5M | -$864.0K | -$5.9M |
| Net cash used in investing activities | -$161.1M | -$36.5M | -$56.5M |
| Stock-based compensation tax withholdings | -$10.6M | -$12.4M | -$3.1M |
| Purchase of company stock and related excise taxes | -$310.0M | -$252.7M | -$250.3M |
| Proceeds from issuance of debt | $229.5M | $50.0M | $0 |
| Repayments of debt principal | -$5.0M | -$6.4M | -$6.0M |
| Retirement of debt obligations | -$180.2M | $0 | $0 |
| Deferred financing costs | -$3.4M | -$77.0K | $0 |
| Other financing activities | $2.3M | $3.4M | -$5.8M |
| Net cash used in financing activities | -$277.3M | -$218.2M | -$265.1M |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | -$179.9M | $68.7M | $49.7M |
| Cash paid for interest | $64.7M | $71.6M | $69.8M |
| Income Taxes Paid, Net | $67.3M | $64.5M | $75.2M |
| Cash paid for operating leases | $30.7M | $28.5M | $27.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Option Care Health, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerJohn Charles Rademacher Aug 7, 2019 to now12
- Chief executive officerDaniel E. Greenleaf Sep 23, 2016 to May 20, 201913
- Chief executive officerRichard H. Friedman Nov 14, 2006 to Apr 28, 201114
- ChairRichard H. Friedman Nov 14, 2006 to Apr 28, 201114
- Chief financial officerMeenal Sethna Oct 3, 2025 to now15
- Chief financial officerMichael H. Shapiro Aug 7, 2019 to Oct 3, 202516
- Chief financial officerStephen Deitsch Apr 25, 2017 to May 20, 201917
- Chief financial officerJeffrey M. Kreger Apr 28, 2015 to Mar 17, 201718
- Chief financial officerHai Tran May 23, 2012 to Jun 2, 201419
- Chief financial officerMary Jane Graves Feb 7, 2011 to Feb 14, 201220
- Chief financial officerDavid W. Froesel Jr. Dec 3, 2010 to Dec 3, 201021
- Chief financial officerStanley Rosenbaum Jun 19, 2006 to Aug 5, 201022
- Chief operating officerLuke Whitworth Jan 25, 2023 to now23
- Chief operating officerHarriet Booker Nov 30, 2017 to Jun 8, 202224
- Chief operating officerJames C. Luthin Aug 11, 2015 to Jul 8, 201625
- Chief operating officerThomas F. Pettit Jul 21, 2014 to Oct 28, 201426
Board members and other officers (68)
- EVP Sp Sales & SolutionsPrateek Bhatia Jul 8, 2026 to now27
- Chief Medical OfficerFemi Adewunmi Apr 23, 2024 to now28
- Chief Accounting OfficerNicole Maggio Aug 9, 2024 to now29
- Chief Human Resources OfficerMichael Bavaro Jan 25, 2023 to now30
- Chief Growth OfficerChristopher L. Grashoff Dec 15, 2023 to now31
- Gen. Counsel & Corp. Secy.Collin Smyser Apr 22, 2022 to now32
- Chief Medical OfficerSeema Kumbhat Aug 19, 2021 to Feb 22, 202233
- CHIEF GROWTH OFFICERChristopher Frederick Hartman Aug 7, 2019 to Aug 7, 201934
- OfficerClifford E. Berman Aug 7, 2019 to Jul 13, 202135
- CHIEF ACCOUNTING OFFICERRobert R. Kampstra Aug 7, 2019 to Jul 13, 202136
- Chief Commercial OfficerRichard Denness Jul 17, 2018 to Mar 13, 202337
- Chief Human Resources OfficerLeslie McIntosh Aug 3, 2018 to Aug 3, 201838
- Chief Accounting OfficerGerald Anthony Lopez Dec 1, 2017 to Dec 1, 201739
- Senior Vice PresidentAlex Schott Sep 23, 2016 to May 7, 201840
- Chief Commercial OfficerGeorge Gregory Meadows Sep 23, 2016 to Sep 23, 201641
- Chief Compliance OfficerMelanie Sponholz Sep 23, 2016 to Sep 23, 201642
- Chief Compliance OfficerJody Kepler Dec 27, 2016 to Apr 11, 201943
- SVP Human ResourcesDonna Trujillo Jan 12, 2015 to Aug 11, 201544
- VP, Chief Accounting OfficerC. Britt Jeffcoat Jun 2, 2015 to Mar 17, 201745
- Chief Compliance OfficerBetty Y. Jang Nov 4, 2015 to Nov 4, 201546
- SVP, Chief Strategy OfficerKaren W. Cain May 30, 2014 to Sep 25, 201547
- SVP National Infusion SalesBrian Edward Stiver Mar 18, 2013 to Sep 25, 201548
- SVP Field OperationsDana Worden Soper Oct 1, 2013 to Nov 7, 201349
- Compliance OfficerBarbara Cormier Apr 3, 2012 to Apr 1, 201350
- Vice President, PBM ServicesDaniel Colucci Apr 3, 2012 to Jun 2, 201451
- Vice President, FinancePatricia Bogusz May 3, 2011 to Jun 2, 201452
- Senior Vice PresidentVito Ponzio Jr. May 3, 2011 to Jun 2, 201453
- SVP, Specialty ServicesMichael Saracco Jun 23, 2010 to Mar 12, 201254
- Executive Vice PresidentThomas Ordemann May 1, 2008 to Dec 1, 200955
- Vice President Mail OperationsRussel J. Corvese Apr 17, 2007 to Feb 13, 201356
- Executive Vice PresidentBarry A. Posner Nov 14, 2006 to Apr 28, 201157
- EVPBrian J. Reagan Nov 14, 2006 to Jan 21, 200958
- Board memberBarbara W. Bodem Jan 9, 2024 to now59
- Board memberNorman L. Wright Jan 9, 2024 to now60
- Board memberEric Brandt May 17, 2024 to now61
- Board memberAaron Friedman May 24, 2022 to May 24, 202262
- Board memberAnita M. Allemand May 24, 2022 to May 24, 202263
- Board memberElizabeth D. Bierbower May 24, 2022 to now64
- Board memberNatasha Deckmann May 24, 2022 to now65
- Board memberPaul J. Finnegan Jul 24, 2020 to Sep 21, 202166
- Board memberSamuel M. Mencoff Jul 24, 2020 to Sep 21, 202166
- Board memberAlan Troy Nielsen Aug 7, 2019 to May 13, 202067
- Board memberElizabeth Quadros Betten Aug 7, 2019 to now68
- Board memberHarry M. Jansen Kraemer Jr. Aug 7, 2019 to now69
- Board memberJohn Arlotta Aug 7, 2019 to May 17, 202470
- Board memberJohn Charles Rademacher Aug 7, 2019 to now12
- Board memberMark Edmund Vainisi Aug 7, 2019 to Aug 7, 201971
- Board memberNitin Sahney Aug 7, 2019 to Jun 7, 202372
- Board memberTimothy P. Sullivan Aug 7, 2019 to now73
- Board memberSteven Neumann Jan 30, 2017 to Jan 30, 201774
- Board memberMichael G. Bronfein Apr 21, 2016 to Jun 5, 201975
- Board memberAdam Gray Mar 11, 2015 to Jul 10, 201976
- Board memberChristopher S. Shackelton Mar 11, 2015 to Jul 10, 201976
- Board memberDavid W. Golding May 20, 2015 to now77
- Board memberMichael Goldstein May 20, 2015 to Jun 5, 201978
- Board memberR. Carter Pate May 20, 2015 to now79
- Board memberTricia Nguyen Jan 23, 2014 to May 4, 201780
- Board memberYon Jorden May 12, 2014 to Mar 13, 201581
- Board memberRichard H. Friedman Jun 3, 2008 to Apr 17, 201282
- Board memberSteven Karl Schelhammer May 22, 2007 to Apr 30, 200983
- Board memberCharlotte W. Collns May 24, 2006 to May 12, 201484
- Board memberStuart A. Samuels May 24, 2006 to May 12, 201485
- Board memberDavid R. Hubers May 25, 2006 to May 12, 201486
- Board memberLouis Difazio Dr. May 25, 2006 to Apr 28, 201187
- Board memberMichael Kooper May 25, 2006 to Jan 23, 200888
- Board memberMyron Z. Holubiak May 25, 2006 to Jun 2, 201689
- Board memberRichard L. Robbins May 25, 2006 to May 12, 201490
- General counselKathryn Stalmack Aug 14, 2018 to Apr 18, 201991
Former names
Timeline
Filings
365 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 50 major events, 215 insider forms, 29 large holders, 51 other. The latest 20:
- Oct 6, 2026DEFA14A EDGAR
- Oct 6, 2026DEFA14A EDGAR
- Oct 6, 20268-K EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Jul 29, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jul 8, 20264 EDGAR
- Jul 8, 20263 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20264 EDGAR
- May 22, 20268-K EDGAR
- May 21, 20264 EDGAR
- May 12, 20268-K EDGAR
- May 7, 20264 EDGAR
The 365 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 29 such filings since October 2021, the latest 10:
- Aug 14, 2026SCHEDULE 13G/A
- May 6, 2026SCHEDULE 13G/A
- Apr 30, 2026SCHEDULE 13G
- Apr 29, 2026SCHEDULE 13G
- Mar 27, 2026SCHEDULE 13G/A
- Nov 5, 2025SCHEDULE 13G
- Aug 12, 2025SCHEDULE 13G/A
- Jun 13, 2025SCHEDULE 13G
- Dec 4, 2024SCHEDULE 13G/A
- Nov 8, 2024SC 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 22,104,863 | $463.5M | 0.0% | +2,217,031 |
| Wellington Management Group Llp | 11,782,384 | $247.1M | 0.0% | −115,083 |
| Vanguard Portfolio Management LLC | 8,274,458 | $173.5M | 0.0% | +211,903 |
| Fuller & Thaler Asset Management, Inc. | 7,450,698 | $156.2M | 0.4% | +325,418 |
| Vanguard Capital Management LLC | 7,063,747 | $148.1M | 0.0% | +47,424 |
| Durable Capital Partners LP | 6,163,722 | $129.3M | 1.3% | −2,827,532 |
| State Street Corp | 6,139,898 | $128.8M | 0.0% | +265,018 |
| Arrowstreet Capital, Limited Partnership | 5,980,270 | $125.4M | 0.1% | +1,744,033 |
| Dimensional Fund Advisors LP | 5,449,294 | $114.3M | 0.0% | +1,572,438 |
| Geode Capital Management, LLC | 4,467,797 | $93.7M | 0.0% | +219,576 |
| Millennium Management LLC | 2,618,869 | $54.9M | 0.0% | +977,878 |
| Charles Schwab Investment Management Inc | 2,464,334 | $51.7M | 0.0% | −24,199 |
| Bank Of America Corp /de/ | 2,266,839 | $47.5M | 0.0% | +321,824 |
| Morgan Stanley | 2,240,837 | $47.0M | 0.0% | −573,415 |
| Goldman Sachs Group Inc | 2,165,092 | $45.4M | 0.0% | +791,302 |
| Sumitomo Mitsui Trust Group, Inc. | 2,132,614 | $44.7M | 0.0% | −478,333 |
| Northern Trust Corp | 1,961,486 | $41.1M | 0.0% | +16,486 |
| Boston Partners | 1,952,275 | $41.0M | 0.0% | −479,192 |
| Nuveen, LLC | 1,938,948 | $40.7M | 0.0% | +318,076 |
| Swedbank AB | 1,891,500 | $39.7M | 0.0% | +165,500 |
| Fmr LLC | 1,819,131 | $38.1M | 0.0% | −4,606,988 |
| Point72 Asset Management, L.P. | 1,800,244 | $37.8M | 0.1% | +1,237,540 |
| Norges Bank | 1,673,104 | $35.1M | 0.0% | New |
| Manufacturers Life Insurance Company, The | 1,633,818 | $34.3M | 0.0% | −171,053 |
| Citadel Advisors LLC | 1,633,556 | $34.3M | 0.0% | −1,903,902 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
4 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Oct 31, 2025 | Lisa C. McClainRepublican, House | Sale | $1,001 - $15,000 | −6.8% | Report |
| Oct 30, 2025 | Lisa C. McClainRepublican, House | Buy | $1,001 - $15,000 | +5.6% | Report |
| Oct 30, 2025 | Lisa C. McClainRepublican, House | Sale | $1,001 - $15,000 | −5.6% | Report |
| Sep 25, 2025 | Lisa C. McClainRepublican, House | Buy | $1,001 - $15,000 | −0.9% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARHai Tran, Chief financial officer
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARFemi Adewunmi, Chief Medical Officer
- 29
- 30
- 31
- 32
- 33SEC EDGARSeema Kumbhat, Chief Medical Officer
- 34
- 35SEC EDGARClifford E. Berman, Officer
- 36
- 37
- 38
- 39
- 40SEC EDGARAlex Schott, Senior Vice President
- 41
- 42
- 43
- 44SEC EDGARDonna Trujillo, SVP Human Resources
- 45
- 46
- 47
- 48
- 49
- 50SEC EDGARBarbara Cormier, Compliance Officer
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58SEC EDGARBrian J. Reagan, EVP
- 59SEC EDGARBarbara W. Bodem, Board member
- 60SEC EDGARNorman L. Wright, Board member
- 61SEC EDGAREric Brandt, Board member
- 62SEC EDGARAaron Friedman, Board member
- 63SEC EDGARAnita M. Allemand, Board member
- 64SEC EDGARElizabeth D. Bierbower, Board member
- 65SEC EDGARNatasha Deckmann, Board member
- 66SEC EDGARPaul J. Finnegan, Board member
- 67SEC EDGARAlan Troy Nielsen, Board member
- 68
- 69
- 70SEC EDGARJohn Arlotta, Board member
- 71SEC EDGARMark Edmund Vainisi, Board member
- 72SEC EDGARNitin Sahney, Board member
- 73SEC EDGARTimothy P. Sullivan, Board member
- 74SEC EDGARSteven Neumann, Board member
- 75SEC EDGARMichael G. Bronfein, Board member
- 76SEC EDGARAdam Gray, Board member
- 77SEC EDGARDavid W. Golding, Board member
- 78SEC EDGARMichael Goldstein, Board member
- 79SEC EDGARR. Carter Pate, Board member
- 80SEC EDGARTricia Nguyen, Board member
- 81SEC EDGARYon Jorden, Board member
- 82SEC EDGARRichard H. Friedman, Board member
- 83
- 84SEC EDGARCharlotte W. Collns, Board member
- 85SEC EDGARStuart A. Samuels, Board member
- 86SEC EDGARDavid R. Hubers, Board member
- 87SEC EDGARLouis Difazio Dr., Board member
- 88SEC EDGARMichael Kooper, Board member
- 89SEC EDGARMyron Z. Holubiak, Board member
- 90SEC EDGARRichard L. Robbins, Board member
- 91SEC EDGARKathryn Stalmack, General counsel
- 92